undamentalytics Newsletter
Sign in

Healthcare Triangle, Inc. income statement

In fiscal 2025, Healthcare Triangle, Inc. reported revenue of $13.9m, up 18.8% on the year before, operating income of −$9.8m (a -70.5% margin) and net income of −$9.5m, or −$152.30 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue31354633121426
Cost of revenue2325352691220
Gross profit911111,0701,0701,2356
Research and development2581010
Selling, general and administrative—00————
Selling and marketing———5235
General and administrative2——64713
Operating income1−5−16−8−5−10−15
Interest expense0101—10
Net interest income—−1−0−1−1−1−0
Provision for credit losses————−00—
Income before tax3−6−14−9−6−9−17
Income tax00100——
Net income2−6−14−9−6−9−17
Diluted EPS$0.84−$2.02−$3.88−$2.08−$16909.30−$152.30—
Diluted shares (average)3m3m4m4m———
EBITDA2−4−13−6−4−9−13

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: DRIO vs HCTIHCTI vs SOPHHCTI vs MNDR

More: Health Care Technology stocks compared, Health Care sector, rankings of US companies

Figures from Healthcare Triangle, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Healthcare Triangle, Inc.